Skip to main content
Hit enter to search or ESC to close
Close Search
Bell Direct
  • What You Get
  • Fees
  • Products
  • Investor Solutions
    • Bell Direct Advantage
    • SMSF
      • Setup your SMSF
      • Switch your SMSF
      • Existing Clients
    • Settlement Solutions
      • Settlement Options
      • Macquarie Cash Management Account
      • Macquarie CMA FAQs
    • Experienced investors
  • Insights
    • Overview
    • BDTV Videos
    • Articles
    • Podcasts
    • Reporting Season
  • FAQ
  • Login
  • Join
  • search
  __PRESENT__PRESENT __PRESENT__PRESENT__PRESENT __PRESENT __PRESENT __PRESENT
  • What You Get
  • Fees
  • Products
  • Investor Solutions
    • Bell Direct Advantage
    • SMSF
      • Setup your SMSF
      • Switch your SMSF
      • Existing Clients
    • Settlement Solutions
      • Settlement Options
      • Macquarie Cash Management Account
      • Macquarie CMA FAQs
    • Experienced investors
  • Insights
    • Overview
    • BDTV Videos
    • Articles
    • Podcasts
    • Reporting Season
  • FAQ
  • Login
  • Join

Results For "NEU"

148 results found

From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

Between the Bells

From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

Weekly Wrap 27 March Blog Post

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Between the Bells

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

2026 8 in 8 Bell Potter’s Bell Potter Healthcare Horizons Summit in Sorrento Melbourne

CY25: gold glitters, AI accelerates and defence dominates. Are markets set for one more Santa rally? Blog Post

Between the Bells

Morning Bell 21 October

Morning Bell 21 October

Weekly Wrap 10 October Blog Post

Bellcast Cover Image

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

Weekly Wrap 29th August Blog Post

Weekly Wrap 15 August Blog Post

Weekly Wrap 8 August Blog Post

Weekly Wrap 25 July Blog Post

Between the Bells

Morning Bell 14 July

Morning Bell 14 July

1 2 3 … 9 Next
Bell Direct
  • Login
  • Join
  • About us
  • Compare us
  • Contact
  • FAQ

WeMoney 2026
Best for Market Research Insights

WeMoney - Winner 2025 - Best for market research insights.

WeMoney 2025
Best for Market Research Insights

WeMoney - Winner 2026 - Best for IPO Access.

WeMoney 2026
Best for IPO Access
Investment Trends Ranked 1st

Highest Overall
Client Satisfaction
2013-2023
© 2026 Bell Direct
  • Terms & Conditions
  • Privacy Policy
  • Financial Services Guide
The Bell Direct service is provided by Third Party Platform Pty Limited trading as "Bell Direct" (ABN 74 121 227 905) an Australian Financial Services licensee (AFSL 314341) a Participant of the ASX Limited Group and a Trading Participant of Cboe Australia. Bell Direct does not provide investment advice. You should consider your own financial situation, particular needs and investment objectives before acting on any of the information available on this website.

Bell Direct Mobile App Waitlist

Enter your details to join our mobile app waitlist and receive early access to the Bell Direct App.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.